MAPT and Alzheimer disease: With current imaging techniques allowing for in vivo quantification of brain iron, Aβ, tau, and neurodegeneration, the efficacy of the disease modifying therapy on these AD pathologies could be more specifically monitored (Borlongan, 2012).